Exposed: NIH Owns Patent for Moderna’s Covid19 Vaccine

Headlines Health Politics Technology U.S.

New documents obtained by Axios and Public Citizen reveal that the National Institutes of Health (NIH) owns half of the patent of a Covid19 vaccine being developed by biotech firm Moderna. That means the NIH could potentially collect half of the royalties of any vaccine after it reaches market and begins to be administered publicly.

Additionally, four NIH scientists have filed their own patent applications as co-inventors of the vaccine. NIH regulations allow scientists to collect up to $150,000 in annual royalties from vaccines they help develop and bring to market – a seeming moral hazard.

Dr. Anthony Fauci allowed Moderna to skip animal trials for their vaccine. He also arranged for a $483 million grant to Modern from another NIH agency, BARDA.

Last month the Association of American Surgeons & Physicians filed a lawsuit against the FDA, HHS, and BARDA, for what it called interference with patients attempting to obtain the already-available drug Hydroxychloroquine to treat Covid19.

Moderna is currently working on vaccines that use mRNA technology. With such vaccines mRNA “instructions” are injected into the body and are delivered to ribosomes within human cells, which are akin to the body’s factory assembly lines. Ribosomes then take those instructions and manufacture proteins in a human body.

Just about every bodily function that exists is carried out by proteins.

So mRNA therapy is not just a way of vaccinating people, but turning their bodies into vaccine factories.

Moderna is heavily funded by the Bill & Melinda Gates Foundation.

This story was originally reported by Robert F. Kennedy, Jr. You can read more of the report here.

Photo by Bicanski on Pixnio

Join the discussion